“He Yuan Li Ji” was established as a joint venture between He Yuan Bio (stock code: 688238) and Li Ji Bio, with its core business centered on the “Li Ji Bio” and “Life-ilab” reagent brands.

Select language:

中文

English

Can a mycoplasma eradication agent be used in combination with a dual‑antibody regimen?

Publication date:2026-10-29
Page views:

It must not be mixed with any other antibiotics except the streptomycin–tetracycline double‑resistance formulation.

Li Ji Bio’s Quick Cell Mycoplasma Eradication Reagent (1000X) effectively inhibits mycoplasma DNA replication by suppressing the activity of mycoplasma DNA gyrase, thereby eliminating mycoplasmas at the genetic level. This ensures that cells are completely free from mycoplasma contamination, safeguarding the reliability of experimental results.

It is primarily used to eliminate mycoplasma from cells, serum, and culture media, with the entire process taking only 3–5 days. This product effectively eradicates most mycoplasma species while being non‑toxic to the cells themselves.

Li Ji has validated over a hundred cell lines, including mouse embryonic stem cells and iPS cells, human embryonic stem cells and iPS cells, HEK293, HeLa, HepG2, HCT116, COS-7, Vero, Huh-7, MDCK, PANC-1, SW620, U2OS, MCF-7, MRC-5, NIH-3T3, CCC-ESF, CHO-S, CHO-K1, CHO-DG44, H295R, HL60, K562, MDA-MB-231, SP20, T47D, BM, and BV2, among others.